维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

10篇 您的检索式：作者名="Dewan Ren"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Comparison of adaptive statistical iterative and filtered back projection reconstruction techniques in brain CT显示文摘	Ren Q Dewan SK Li M	2012	Eur J Radiology2012，81，10：	1
	2	Risk and Return of Information Technology Initiatives : Evidence from Electronic Commerce Announcements 显示文摘	Dewan S Ren F	2007	Information Systems Research2007，18，4：	1
	3	Risk and return of information tech?nology initiatives: Evidence from electronic commerce announcements显示文摘	Dewan S Ren F	2007	Information Systems Research2007，18，4：	1
	4	Information technology and firm boundaries: Impact on firm risk and rean-n perfor- mance显示文摘	Dewan S Ren F	2011	Information Systems Research2011，22，2：	1
	5	Industry-Level Analysis of Information Technology Return And Risk: What Explains the Varia- tion? 显示文摘	Ren F Dewan S	2015	Journal of Management Information Systems2015，32，2：	1
	6	Information Technology and Firm Boundaries:Impact on Firm Risk and Return Performance 显示文摘	Dewan S Ren F	2011	Information Systems Research2011，22，2：	1
	7	Risk and return of information technology initiatives: Evidence from electronic commerce announcements显示文摘	Dewan S Ren F	2007	Information Systems Research2007，18，4：	1
	8	Information Technology and Firm Boundaries:Impact on Firm Risk and Return Performance 显示文摘	Dewan S and Ren F	2011	Infor- mation Systems Research2011，22，2：	1
	9	Risk and return of information tech nology initiatives:evidence from electronic commerce an- nouncements显示文摘	DEWAN S REN F	2007	Information Systems Research2007，18，4：	1
	10	Transient HSP90 inhibition enhances the sensitivity of mantle cell lymphoma to poly(ADP-ribose)polymerase(PARP)inhibitors显示文摘Mantle cell lymphoma(MCL)is an aggressive subtype of non-Hodgkin lymphoma(NHL)characterized by the overexpression of cyclin D1 and deregulated cell cycle.1 Ganetespib(STA-9090),a second-generation HSP90 inhibitor,dramatically disrupted oncogenic cellular processes resulting in the inhibition of client protein-derived tumors in preclinical studies.2 The synthetic lethal strategy using poly(ADP-ribose)polymerase(PARP)inhibitors(PARPis)has been reported as a powerful therapeutic intervention in MCL and their effectiveness can be increased by a deficiency in DNA damage repair(DDR),especially homologous recombination deficiency.3 Since we found earlier that transient ganetespib treatment can induce defects in DDR,we hypothesized that ganetespib treatment can possibly enhance the sensitivity of MCL cells to PARPis and HSP90 and PARP is can be demonstrated as promising combination therapies for MCL.	Chaowen Shi Dewan Ren Yufeng Gao Ya-Mei Dang Zhigang Tu Hanqing Liu	2023	Genes & Diseases2023，10，5：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费